Document is current
Any future updates will be listed below
-
Authors
Leslie, Lori A.
- License Information
-
More Information
Article History
Accepted: 25 July 2021
First Online: 25 October 2021
Declarations
:
: Lori A. Leslie has received consulting/advisory fees from Bayer, Seattle Genetics, ADC Therapeutics, AbbVie, Janssen, Pharmacyclics, Kite/Gilead, AstraZeneca, and TG Therapeutics, and has received compensation for service on speakers’ bureaus from Seattle Genetics, Bristol-Myers Squibb/Celgene, Kite/Gilead, BeiGene, Pharmacyclics/Janssen, AstraZeneca, Epizyme, Karyopharm Therapeutics, and TG Therapeutics.
